SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Accession No. 0001144204-11-018740
Filing Date
2011-03-31
Accepted
2011-03-31 11:35:50
Documents
6
Period of Report
2010-12-31
Filing Date Changed
2011-03-31

Document Format Files

Seq Description Document Type Size
1 v216358_10k.htm 10-K 1866386
2 GRAPHIC chart.jpg GRAPHIC 139227
3 v216358_ex23-1.htm EX-23.1 3515
4 v216358_ex31-1.htm EX-31.1 13456
5 v216358_ex31-2.htm EX-31.2 13333
6 v216358_ex32-1.htm EX-32.1 5971
  Complete submission text file 0001144204-11-018740.txt   2095854
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 11724500
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1